| pubmed-article:2395285 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2395285 | lifeskim:mentions | umls-concept:C0004886 | lld:lifeskim |
| pubmed-article:2395285 | lifeskim:mentions | umls-concept:C0021083 | lld:lifeskim |
| pubmed-article:2395285 | lifeskim:mentions | umls-concept:C0005695 | lld:lifeskim |
| pubmed-article:2395285 | lifeskim:mentions | umls-concept:C0750540 | lld:lifeskim |
| pubmed-article:2395285 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:2395285 | pubmed:dateCreated | 1990-10-10 | lld:pubmed |
| pubmed-article:2395285 | pubmed:abstractText | Clinical experience is recorded and summarized with the application of BCG vaccine for prophylaxis, treatment and immunochemotherapy of bladder tumors for the period June 1985-January 1988. Included in the study were 85 patients distributed in five groups: 23 patients treated for prevention of relapses; 26 treated for existing and residual surface tumors; 13 in whom BCG vaccine F-70 was applied for prophylaxis purpose; 17 with surface tumors treated only surgically--control group; 10 patients with advanced bladder tumor treated with immunochemotherapeutic agents. Once the results have been reported and discussed, the following inferences were made: 1. Intravesical BCG vaccine is a new effective and practicable method for prophylaxis and treatment of surface bladder tumors; 2. A 12-month course of treatment with the new Bulgarian Kalgevax showed high therapeutic activity; 3. Indications and possibilities for treatment of existing and residual surface tumors with intravesical BCG vaccine are given; complete effect of treatment was obtained in 21 patients (81 per cent); 4. The side reactions of the application of BCG vaccine and the possibilities for their reduction are presented; 5. The first results of application of immunotherapy in advanced bladder tumors are encouraging. | lld:pubmed |
| pubmed-article:2395285 | pubmed:language | bul | lld:pubmed |
| pubmed-article:2395285 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2395285 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2395285 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2395285 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2395285 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2395285 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2395285 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2395285 | pubmed:issn | 0450-2167 | lld:pubmed |
| pubmed-article:2395285 | pubmed:author | pubmed-author:TonchevTT | lld:pubmed |
| pubmed-article:2395285 | pubmed:author | pubmed-author:PatrashkovTT | lld:pubmed |
| pubmed-article:2395285 | pubmed:author | pubmed-author:PetrovPP | lld:pubmed |
| pubmed-article:2395285 | pubmed:author | pubmed-author:PetkovTsTs | lld:pubmed |
| pubmed-article:2395285 | pubmed:author | pubmed-author:DamianovKhKh | lld:pubmed |
| pubmed-article:2395285 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2395285 | pubmed:volume | 43 | lld:pubmed |
| pubmed-article:2395285 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2395285 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2395285 | pubmed:pagination | 48-53 | lld:pubmed |
| pubmed-article:2395285 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:2395285 | pubmed:meshHeading | pubmed-meshheading:2395285-... | lld:pubmed |
| pubmed-article:2395285 | pubmed:meshHeading | pubmed-meshheading:2395285-... | lld:pubmed |
| pubmed-article:2395285 | pubmed:meshHeading | pubmed-meshheading:2395285-... | lld:pubmed |
| pubmed-article:2395285 | pubmed:meshHeading | pubmed-meshheading:2395285-... | lld:pubmed |
| pubmed-article:2395285 | pubmed:meshHeading | pubmed-meshheading:2395285-... | lld:pubmed |
| pubmed-article:2395285 | pubmed:meshHeading | pubmed-meshheading:2395285-... | lld:pubmed |
| pubmed-article:2395285 | pubmed:meshHeading | pubmed-meshheading:2395285-... | lld:pubmed |
| pubmed-article:2395285 | pubmed:meshHeading | pubmed-meshheading:2395285-... | lld:pubmed |
| pubmed-article:2395285 | pubmed:meshHeading | pubmed-meshheading:2395285-... | lld:pubmed |
| pubmed-article:2395285 | pubmed:meshHeading | pubmed-meshheading:2395285-... | lld:pubmed |
| pubmed-article:2395285 | pubmed:meshHeading | pubmed-meshheading:2395285-... | lld:pubmed |
| pubmed-article:2395285 | pubmed:meshHeading | pubmed-meshheading:2395285-... | lld:pubmed |
| pubmed-article:2395285 | pubmed:meshHeading | pubmed-meshheading:2395285-... | lld:pubmed |
| pubmed-article:2395285 | pubmed:meshHeading | pubmed-meshheading:2395285-... | lld:pubmed |
| pubmed-article:2395285 | pubmed:year | 1990 | lld:pubmed |
| pubmed-article:2395285 | pubmed:articleTitle | [Nonspecific immunotherapy with BCG vaccine in bladder tumors]. | lld:pubmed |
| pubmed-article:2395285 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2395285 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:2395285 | pubmed:publicationType | English Abstract | lld:pubmed |
